Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Astria Therapeutics, Inc. ATXS | RA CAPITAL MANAGEMENT L.P. | 1,262,193 9.700% | 1,262,193 (New Position) | Filing History |
| 2022-02-08 4:31 pm Sale | 2021-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 911,736 7.000% | -62,869 (-6.45%) | Filing History |
| 2022-01-06 8:15 pm Purchase | 2022-01-06 | 13G | Astria Therapeutics, Inc. ATXS | Rosalind Advisors, Inc. | 653,438 5.000% | 653,438 (New Position) | Filing History |
| 2021-09-22 9:54 pm Unchanged | 2021-09-20 | 13D | Astria Therapeutics, Inc. ATXS | Viridian LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-09-22 3:57 pm Purchase | 2021-09-20 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 974,605 7.600% | 974,605 (New Position) | Filing History |
| 2021-07-09 2:38 pm Purchase | 2021-06-30 | 13G | Astria Therapeutics, Inc. ATXS | FEDERATED HERMES INC. FHI | 260,456 1.990% | 39 (+0.01%) | Filing History |
| 2021-06-25 5:01 pm Purchase | 2021-06-08 | 13D | Astria Therapeutics, Inc. ATXS | Xontogeny LLC | 1,281,198 9.900% | 1,281,198 (New Position) | Filing History |
| 2021-06-25 5:01 pm Purchase | 2021-06-08 | 13D | Astria Therapeutics, Inc. ATXS | Perceptive Advisors LLC | 1,281,198 9.900% | 868,377 (+210.35%) | Filing History |
| 2021-06-17 1:41 pm Purchase | 2021-06-08 | 13D | Astria Therapeutics, Inc. ATXS | Viridian LLC | 1,281,198 9.990% | 1,281,198 (New Position) | Filing History |
| 2021-06-17 1:32 pm Purchase | 2021-06-08 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 682,028 5.300% | 682,028 (New Position) | Filing History |
| 2021-06-15 4:32 pm Purchase | 2021-06-08 | 13G | Astria Therapeutics, Inc. ATXS | RA CAPITAL MANAGEMENT L.P. | 957,624 7.500% | 957,624 (New Position) | Filing History |
| 2021-02-16 07:33 am Sale | 2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Altium Capital Management LLC | 41,667 1.200% | -112,500 (-72.97%) | Filing History |
| 2021-02-16 06:26 am Sale | 2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Corriente Advisors LLC | 0 0.000% | -134,097 (Position Closed) | Filing History |
| 2021-02-12 1:14 pm Unchanged | 2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS | FEDERATED HERMES INC. FHI | 260,417 7.570% | 0 (Unchanged) | Filing History |
| 2021-02-08 5:15 pm Purchase | 2021-01-28 | 13D | Astria Therapeutics, Inc. ATXS | Perceptive Advisors LLC | 412,821 10.500% | 412,821 (New Position) | Filing History |
| 2021-02-02 3:16 pm Purchase | 2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS | BlackRock Inc. BLK | 194,464 5.800% | 194,464 (New Position) | Filing History |